CN104718453B - 酸性条件下分析物测定用方法和试剂盒 - Google Patents

酸性条件下分析物测定用方法和试剂盒 Download PDF

Info

Publication number
CN104718453B
CN104718453B CN201380051645.1A CN201380051645A CN104718453B CN 104718453 B CN104718453 B CN 104718453B CN 201380051645 A CN201380051645 A CN 201380051645A CN 104718453 B CN104718453 B CN 104718453B
Authority
CN
China
Prior art keywords
analyte
protein
acid
sample
complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201380051645.1A
Other languages
English (en)
Chinese (zh)
Other versions
CN104718453A (zh
Inventor
M·因加纳斯
P·莱赫托宁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gyros Patent AB
Original Assignee
Gyros Patent AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gyros Patent AB filed Critical Gyros Patent AB
Publication of CN104718453A publication Critical patent/CN104718453A/zh
Application granted granted Critical
Publication of CN104718453B publication Critical patent/CN104718453B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/5375—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by changing the physical or chemical properties of the medium or immunochemicals, e.g. temperature, density, pH, partitioning
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
CN201380051645.1A 2012-10-03 2013-10-03 酸性条件下分析物测定用方法和试剂盒 Active CN104718453B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE1251116-8 2012-10-03
SE1251116 2012-10-03
SE1350373-5 2013-03-25
SE1350373 2013-03-25
PCT/SE2013/051161 WO2014055025A1 (en) 2012-10-03 2013-10-03 Method and kit for analyte determination at acidic conditions

Publications (2)

Publication Number Publication Date
CN104718453A CN104718453A (zh) 2015-06-17
CN104718453B true CN104718453B (zh) 2017-03-08

Family

ID=50435248

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380051645.1A Active CN104718453B (zh) 2012-10-03 2013-10-03 酸性条件下分析物测定用方法和试剂盒

Country Status (5)

Country Link
US (1) US10036745B2 (enExample)
EP (1) EP2904393B1 (enExample)
JP (1) JP6279590B2 (enExample)
CN (1) CN104718453B (enExample)
WO (1) WO2014055025A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118443922A (zh) * 2016-09-06 2024-08-06 富士瑞必欧株式会社 肿瘤标记物的测定方法及测定试剂
CN109477832A (zh) * 2016-09-06 2019-03-15 富士瑞必欧株式会社 甲状腺球蛋白的测定方法及测定试剂
JP6999561B2 (ja) * 2016-09-13 2022-02-10 富士レビオ株式会社 心筋トロポニンの測定方法及び測定試薬
PL3717916T3 (pl) * 2017-11-29 2025-04-07 F. Hoffmann-La Roche Ag Test do oznaczania przeciwciał przeciwlekowych z tłumieniem oddziaływania z cząsteczką docelową
ES3038185T3 (en) * 2018-08-03 2025-10-10 Bristol Myers Squibb Co Methods for detecting anti-drug antibodies
CN113960318A (zh) * 2021-09-28 2022-01-21 苏州赛分科技股份有限公司 一种基于酶联免疫的重组蛋白a测定方法及试剂盒
KR20250037485A (ko) * 2022-07-13 2025-03-17 리제너론 파마슈티칼스 인코포레이티드 분석물 검출을 위한 약산 면역분석법

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0213093A1 (en) * 1985-06-03 1987-03-04 Pharmacia Ab Immunoassay method for the determination of Fc-part binding bacterial polypeptides and/or corresponding antibodies
WO1991010911A1 (en) * 1990-01-19 1991-07-25 Repligen Corporation Immunoassay of protein a under acidic conditions
CN101097217A (zh) * 2006-06-29 2008-01-02 王珊珊 一种提高血清特异性生长因子免疫学测定灵敏度的技术
WO2009022001A1 (en) * 2007-08-16 2009-02-19 Novartis Ag Improvement of drug tolerance in immunogenicity testing
CN101583872A (zh) * 2006-09-14 2009-11-18 通用电气健康护理生物科学股份公司 测定待分析物浓度的方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4703001A (en) * 1985-10-23 1987-10-27 Synbiotics, Corporation Immunoassay for the detection of serum analytes using pH dependent chastropic acids
US5314804A (en) * 1992-03-24 1994-05-24 Serim Research Corporation Test for Helicobacter pylori
GB9809943D0 (en) 1998-05-08 1998-07-08 Amersham Pharm Biotech Ab Microfluidic device
AU2002243148A1 (en) 2001-03-19 2002-10-03 Gyros Ab Structural units that define fluidic functions
WO2002075312A1 (en) 2001-03-19 2002-09-26 Gyros Ab Characterization of reaction variables
WO2003018198A1 (en) 2001-08-28 2003-03-06 Gyros Ab Retaining microfluidic microcavity and other microfluidic structures
WO2003076568A2 (en) * 2002-02-11 2003-09-18 Alexion Pharmaceuticals, Inc. Immunotherapeutics for biodefense
SE0200943D0 (sv) 2002-03-25 2002-03-25 Amersham Biosciences Ab Mutant protein
JP4115728B2 (ja) 2002-03-26 2008-07-09 デンカ生研株式会社 フロースルー式検査法用組成物、これを用いたキット及び検査法
JP4423189B2 (ja) * 2002-05-31 2010-03-03 ユィロス・パテント・アクチボラグ 表面プラズモン共鳴に基づく検出装置
SE0300822D0 (sv) 2003-03-23 2003-03-23 Gyros Ab A collection of Micro Scale Devices
EP1608587B1 (en) 2003-03-23 2016-11-23 Gyros Patent Ab Preloaded microscale devices
EP2062052A4 (en) 2006-09-14 2010-02-03 Ge Healthcare Bio Sciences Ab METHOD FOR DETERMINING ANALYZ CONCENTRATION
WO2008043075A2 (en) * 2006-10-05 2008-04-10 Wyeth Compositions for the treatment of scleritis
CN101965516A (zh) 2008-04-03 2011-02-02 弗·哈夫曼-拉罗切有限公司 聚乙二醇化胰岛素样生长因子测定
JP5710482B2 (ja) 2008-09-11 2015-04-30 アンスティテュ・パストゥール Ｈｍｇｂ１依存型誘発のｈｉｖ−１複製および持続の調節によるヒト免疫不全ウイルス感染の監視および阻害
US8546149B2 (en) 2010-08-27 2013-10-01 Intervet Inc. Potency test for vaccine formulations
ES2530175T3 (es) * 2011-02-17 2015-02-26 Nestec S.A. Ensayos para la detección de autoanticuerpos contra fármacos anti-TNF
KR102076354B1 (ko) * 2012-02-15 2020-02-10 바이오콘 리미티드 분석물의 검출 및 선택적인 정량화를 위한 공정

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0213093A1 (en) * 1985-06-03 1987-03-04 Pharmacia Ab Immunoassay method for the determination of Fc-part binding bacterial polypeptides and/or corresponding antibodies
WO1991010911A1 (en) * 1990-01-19 1991-07-25 Repligen Corporation Immunoassay of protein a under acidic conditions
CN101097217A (zh) * 2006-06-29 2008-01-02 王珊珊 一种提高血清特异性生长因子免疫学测定灵敏度的技术
CN101583872A (zh) * 2006-09-14 2009-11-18 通用电气健康护理生物科学股份公司 测定待分析物浓度的方法
WO2009022001A1 (en) * 2007-08-16 2009-02-19 Novartis Ag Improvement of drug tolerance in immunogenicity testing

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
An acid dissociation bridging ELISA for detection of antibodies directed against therapeutic proteins in the presence of antigen;Aaron Patton 等;《Journal of Immunological Methods 》;20050725;第304卷;189-195 *
An Affinity Capture Elution (ACE) assay for detection of anti-drug antibody to monoclonal antibody therapeutics in the presence of high levels of drug;James S. Bourdage 等;《Journal of Immunological Methods》;20070727;第327卷;10-17 *
Detection of antibodies against therapeutic proteins in the presence of residual therapeutic protein using a solid-phase extraction with acid dissociation (SPEAD) sample treatment prior to ELISA;Holly W. Smith 等;《Regulatory Toxicology and Pharmacology》;20070807;第49卷;230-237 *
Improvement of drug tolerance in immunogenicity testing by acid treatment on Biacore;Denise Sickert 等;《Journal of Immunological Methods》;20080214;第334卷;29-36 *

Also Published As

Publication number Publication date
JP6279590B2 (ja) 2018-02-14
WO2014055025A1 (en) 2014-04-10
JP2015531487A (ja) 2015-11-02
EP2904393A1 (en) 2015-08-12
EP2904393B1 (en) 2018-11-28
US10036745B2 (en) 2018-07-31
CN104718453A (zh) 2015-06-17
EP2904393A4 (en) 2016-05-04
US20150268238A1 (en) 2015-09-24

Similar Documents

Publication Publication Date Title
CN104718453B (zh) 酸性条件下分析物测定用方法和试剂盒
Zhang et al. High performance affinity chromatography and related separation methods for the analysis of biological and pharmaceutical agents
US10648988B2 (en) Methods for providing information relevant to diagnosis of neurodegenerative disorder
WO2004011607A2 (en) Reagent and method for determination of a substance using an immunoaggregator
Miyazaki et al. Evidence for the presence of lipid-free monomolecular apolipoprotein A-1 in plasma
KR20160031550A (ko) 펩티드 단편의 조제 방법 및 그것에 사용되는 펩티드 단편 조제용 킷, 및 분석 방법
JP2012519208A (ja) ビタミンｄを検出するためのアッセイおよびそのための抗体
JP7382071B2 (ja) 糖化ヘモグロビン（％）の測定方法
JP2023533806A (ja) タウオパチー又はアミロイド形成疾患を検出するための血液ベースのアッセイ
WO2013170057A2 (en) Quantification of lipoproteins
US20050095726A1 (en) Novel high protein tortillas
US8153381B2 (en) Methods for detection of the strain of a pathogen
JP2017187476A (ja) 変性抗体測定方法
EP3531129A1 (en) Immunoassay method using anti-human bnp fragment (4-32) antibody
JP2005524087A (ja) サンドイッチアッセイおよびキット
US20210055300A1 (en) Monoclonal antibody against apoa4, immunological measurement method, and kit for measurement
US9151747B1 (en) Sucralose antibody and immunoassay
JP5231954B2 (ja) アルブミン測定試薬
JP6152908B2 (ja) ペプチド断片の調製方法および分析方法
DelGuidice et al. Intact quantitative bioanalytical method development and fit-for-purpose validation of a monoclonal antibody and its related fab fragment in human vitreous and aqueous humor using LC-HRMS
Tillib et al. Development of an anchor bispecific nanoantibody to improve the efficiency of antigen immobilization and detection in a well of a polystyrene plate
US20180246121A1 (en) Immunological test method and immunological test kit
US20060275849A1 (en) Monoclonal antibody reagents
JP4753366B2 (ja) ％ｃｄｔの定量方法
CN119827779A (zh) 维生素d均相检测方法和试剂

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant